$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Pharmaceutical preparation for oral cavity administration 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/22
  • A61K-031/78
  • A61K-031/45
  • A61K-009/26
출원번호 US-0615301 (1975-09-22)
우선권정보 JA-0108891 (1974-09-24)
발명자 / 주소
  • Tanaka Wataru (Hoya JA) Akito Eiichiro (Omiya JA) Yoshida Koichi (Soka JA) Terada Takashi (Yono JA) Ninomiya Hiroshi (Sayama JA)
출원인 / 주소
  • Nippon Kayaku Kabushiki Kaisha (Tokyo JA 03)
인용정보 피인용 횟수 : 35  인용 특허 : 0

초록

A pharmaceutical preparation of oral cavity administration, characterized by being a mixture of a pharmacologically active agent, a pharmaceutical carrier, and sodium polyacrylate, in conventional dosage form. It has advantages in that it adheres strongly to local site and dissolves gradually over a

대표청구항

A pharmaceutical preparation for oral cavity administration comprising 10 to 60% by weight of sodium polyacrylate, 90 to 10% by weight of a pharmaceutical carrier selected from the group consisting of an excipient and ointment, and 50 to 0.05% by weight of a pharmacologically active agent.

이 특허를 인용한 특허 (35)

  1. Fischer, Andreas, Abuse-resistant pharmaceutical composition for the treatment of opioid dependence.
  2. Fischer, Andreas, Abuse-resistant pharmaceutical composition for the treatment of opioid dependence.
  3. Fischer, Andreas, Abuse-resistant pharmaceutical composition for the treatment of opioid dependence.
  4. Fischer, Andreas, Abuse-resistant pharmaceutical composition for the treatment of opioid dependence.
  5. Connor, Robert A., Adjustable gastrointestinal bifurcation (AGB) for reduced absorption of unhealthy food.
  6. Krueger James E. (New City NY) Carpentier Eugene A. (Spring Valley NY), Amorphous coprecipitates of 4-(monoalkylamino) benzoic acid and derivatives and certain water-soluble materials.
  7. Babaian Eduard A. (Moscow SUX) Gerasimova Galina A. (Moscow SUX) Davydov Anatoly B. (Moscow SUX) Utyamyshev Rustam I. (Moscow SUX) Khromov Gennady L. (Moscow SUX) Metelitsa Vladimir I. (Moscow SUX) V, Antianginal film and method of treating ischemic heart disease.
  8. Babaian Eduard A. (Moscow SUX) Gerasimova Galina A. (Moscow SUX) Davydov Anatoly B. (Moscow SUX) Utyamyshev Rustam I. (Moscow SUX) Khromov Gennady L. (Moscow SUX) Metelitsa Vladimir I. (Moscow SUX) V, Antianginal plate for treating ischemic heart disease.
  9. Babaian Eduard A. (ulitsa Novatorov 36 ; Korpus 9 ; kv. 12 Moscow SUX) Gerasimova Galina A. (ulitsa Shepilovskaya 36 ; Korpus 2 ; kv. 131 Moscow SUX) Davydov Anatoly B. (ulitsa Krasny Kazanets 19 ; K, Antianginal plate for treating ischemic heart disease.
  10. Haley, Jeffrey T; Edwards, Steven, Bi-Layer Pressed Powders Oral Adhering Tablet with Acacia gum adhesive.
  11. Berde Charles B. (Brookline MA) Langer Robert S. (Newton MA), Biodegradable polymer matrices for sustained delivery of local anesthetic agents.
  12. Berde Charles B. ; Langer Robert S., Biodegradable polymer matrices for sustained delivery of local anesthetic agents.
  13. Chen, Li-Lan H.; Pfister, William R.; Renn, Donald W.; Buranachokpaisan, Thitiwan; Osborne, James; Tan, Hock Seng; Tao, Li, Compositions and methods for mucosal delivery.
  14. Baker Richard W. (Menlo Park CA), Controlled release drug delivery system for the periodontal pocket.
  15. DeCrosta Mark T. (Plainsboro NJ) Jain Nemichand B. (Monmouth Junction NJ) Rudnic Edward M. (Kendall Park NJ), Controlled release formulation.
  16. Kronenthal Richard L. (Fair Lawn NJ) Mattei Frank V. (Piscataway NJ) Levy Alan J. (Bridgewater NJ), Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition.
  17. Connor, Robert A., Device for selectively reducing absorption of unhealthy food.
  18. Connor, Robert A., Dysgeusia-inducing neurostimulation for modifying consumption of a selected nutrient type.
  19. Kehoe Gary S. (Briarcliff Manor NY), Elastomer encased active ingredients.
  20. Walter Heinzelmann DE; Cornelius Ruloff DE, Fireproof, non-exploding nitroglycerine and solid mixtures containing anhydrous lactose.
  21. Dragan, William B.; Discko, John J., Gingival tissue retraction device and method.
  22. Nagai Tsuneji (Chofu JPX) Machida Yoshiharu (Kawasaki JPX) Suzuki Yoshiki (Hino JPX) Ikura Hiroshi (Hino JPX), Method and preparation for administration to the mucosa of the oral or nasal cavity.
  23. Nagai Tsuneji (Chofu JPX) Machida Yoshiharu (Kawasaki JPX) Suzuki Yoshiki (Hino JPX) Ikura Hiroshi (Hino JPX), Method and preparation for administration to the mucosa of the oral or nasal cavity.
  24. Barr Arthur (2942 Shore Dr. Merrick NY 11566), Method for the oral treatment of dogs and other animals.
  25. Dam Anders,DKX, Nicotine containing stimulant unit.
  26. Pettersson, Anders, Non-abusable pharmaceutical composition comprising opioids.
  27. Ikura Hiroshi (Tokyo JPX) Suzuki Yoshiki (Tokyo JPX) Nagai Tsuneji (Tokyo JPX) Machida Yoshiharu (Kanagawa JPX), Oral sustained release pharmaceutical preparation.
  28. Davydov Anatoly B. (ulitsa Krasny Kazanets ; 19 ; korpus 1 ; kv. 283 Moscow SUX) Babaian Eduard A. (ulitsa Novatorov ; 40 ; korpus 2 ; kv. 50 Moscow SUX) Metelitsa Vladimir I. (Jubileiny prospekt ; 3, Pharmaceutical composition for the treatment of diabetes mellitus.
  29. Lerner E. Itzhak,ILX ; Rosenberger Vered,ILX ; Flashner Moshe,ILX, Pharmaceutical oral patch for controlled release of pharmaceutical agents in the oral cavity.
  30. Miyazaki Hiroshi (Kawasaki JPX) Ohkuma Taka\aki (Tokyo JPX) Minatogawa Yukiko (Tokorozawa JPX) Ninomiya Hiroshi (Sayama JPX), Phthalazinol preparation.
  31. Keith Alec D. (State College PA) Snipes Wallace (State College PA), Polymeric diffusion matrix.
  32. Keith Alec D. (Miami FL), Polymeric diffusion matrix containing propranolol.
  33. Kleinberg Israel (Smithtown NY) Sreebny Leo M. (East Setauket NY), Salivary stimulant.
  34. Suzuki Yoshiki (Hino JPX) Ikura Hiroshi (Hino JPX) Yamashita Gentaro (Koganei JPX), Slow-releasing medical preparation to be administered by adhering to a wet mucous surface.
  35. Kigasawa Kazuo (Tokyo JPX) Shimizu Hiroaki (Tokyo JPX) Hayashi Toshihiro (Chiba JPX) Watabe Kazuo (Kanagawa JPX) Tanizaki Akira (Tokyo JPX) Koyama Osamu (Tokyo JPX) Wakisaka Kikuo (Tokyo JPX) Ogawa Y, Soft buccal.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로